ผง Sermaglutide คุณภาพสูง Semaglutide CAS 910463-68-2
![](/picture_upload/market/full/2023-06/ysSDKj1686810950.jpg)
สินค้าใหม่
1 บาท
![](https://mail-online.nosdn.127.net/wzpmmc/8c37e3237c05e8764269e8cfd58987ce.jpg)
Product Description
Use of Semaglutide acetate salt
Semaglutide, a long-acting GLP-1 analogue, is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes.
Detailed Product Information
Product Name :Tirzepatide
Trade Name: M-ounjaro
CAS No.:2023788-19-2
Purity : 98% HPLC
Appearance: Lyophilized Powder
Typical use: weight loss peptides
Shelf Life :2 years
Storage:Refrigeration keep dry and away from light.
Description:
Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately 5 days allows once-weekly subcutaneous administration. A phase 2b trial involving patients with type 2 diabetes showed that those who received tirzepatide had dose-dependent reductions in the glycated hemoglobin level and weight at 26 weeks.
Once-weekly injectable semaglutide, a selective GLP-1 receptor agonist, is approved for the treatment of type 2 diabetes at doses up to 1 mg. In trials involving patients who received semaglutide, the mean reductions in the glycated hemoglobin level have been reported to be as high as 1.8 percentage points and the mean reductions in body weight have been reported to be as high as 6.5 kg.
We conducted the SURPASS-2 trial (A Study of Tirzepatide [LY3298176] versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants with Type 2 Diabetes) to compare the efficacy and safety of tirzepatide at doses of 5 mg, 10 mg, and 15 mg with those of semaglutide at a dose of 1 mg in patients with type 2 diabetes that had been inadequately controlled with metformin monotherapy.
R-ybelsus (semaglutide) is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
R-ybelsus is usually given after other diabetes medicines have been tried without success.
The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.
Weekly semaglutide 2.4 mg (W-egovy, Novo Nordisk), a GLP-1 receptor agonist, is the first-approved drug for chronic weight management in adults with general obesity or overweight since 2014. Semaglutide is indicated for chronic weight management in adults with a BMI of 27 kg/m² or greater who have at least one weight-related comorbidity, such as type 2 diabetes or hypertension, or in adults with a BMI of at least 30 kg/m²
Semaglutide 1 mg injection (O-zempic) was first approved as a treatment for type 2 diabetes in 2017.
Safety and efficacy of semaglutide 2.4 mg was assessed in four 68-week trials. Three were randomized, double-blind, placebo-controlled trials, including 16 weeks of dose increases, and one was a double-blind, placebo-controlled, randomized withdrawal trial in which patients assigned semaglutide either continued treatment or switched to a placeboSemaglutide 2.4 mg should not be used in combination with other semaglutide-containing products, other GLP-1 receptor agonists or other products intended for weight loss, including prescription drugs, over-the-counter drugs and herbal products, according to the release. Semaglutide 2.4 mg has not been studied in patients with a history of pancreatitis.
This is a once-weekly injectable, which is more tolerable way of managing obesity vs. other treatments. The STEP study data showed semaglutide 2.4 mg crosses the magic threshold of 10% weight loss for many people who received it. This is another tool that will allow clinicians to better manage obesity.
![Raw Materials/Finished Products in Stock Sermaglutide Liraglutide Tirzepatide Gip GLP-1 Injection GLP CAS. 910463-68-2 Treatment](https://image.made-in-china.com/226f3j00BhCbSAcyQYoV/Raw-Materials-Finished-Products-in-Stock-Sermaglutide-Liraglutide-Tirzepatide-Gip-GLP-1-Injection-GLP-CAS-910463-68-2-Treatment.webp)
![Raw Materials/Finished Products in Stock Sermaglutide Liraglutide Tirzepatide Gip GLP-1 Injection GLP CAS. 910463-68-2 Treatment](https://image.made-in-china.com/226f3j00ZVCosGbcEUqh/Raw-Materials-Finished-Products-in-Stock-Sermaglutide-Liraglutide-Tirzepatide-Gip-GLP-1-Injection-GLP-CAS-910463-68-2-Treatment.webp)
CAS | Common Name |
910463-68-2 | Semaglutide acetate salt |
2023788-19-2 | Tirzepatide |
28578-16-7 | PMK ethyl glycidate |
20320-59-6 | Diethyl(phenylacetyl)malonate |
288573-56-8 | tert-butyl 4-(4-fluoroanilino)piperidine-1-carboxylate |
236117-38-7 | 2-iodo-1-p-tolylpropan-1-one |
102-97-6 | Benzylisopropylamine |
52190-28-0 | 2-Bromo-3',4'-(methylenedioxy)p-ropiophenone |
2114-39-8 | 2-bromo-1-phenylpropane |
23076-35-9 | Xylazine hydrochloride |
5061-21-2 | 3-Bromdihydrofuran-2(3H)-on |
59-67-6 | Nicotinic acid |
50-56-6 | Oxytocin acetate salt |
132112-35-7 | Ropivacaine hydrochloride |
![Raw Materials/Finished Products in Stock Sermaglutide Liraglutide Tirzepatide Gip GLP-1 Injection GLP CAS. 910463-68-2 Treatment](https://image.made-in-china.com/226f3j00OPokNYngrscE/Raw-Materials-Finished-Products-in-Stock-Sermaglutide-Liraglutide-Tirzepatide-Gip-GLP-1-Injection-GLP-CAS-910463-68-2-Treatment.webp)
![Raw Materials/Finished Products in Stock Sermaglutide Liraglutide Tirzepatide Gip GLP-1 Injection GLP CAS. 910463-68-2 Treatment](https://image.made-in-china.com/226f3j00OLcbyPNIkKoQ/Raw-Materials-Finished-Products-in-Stock-Sermaglutide-Liraglutide-Tirzepatide-Gip-GLP-1-Injection-GLP-CAS-910463-68-2-Treatment.webp)
![Raw Materials/Finished Products in Stock Sermaglutide Liraglutide Tirzepatide Gip GLP-1 Injection GLP CAS. 910463-68-2 Treatment](https://image.made-in-china.com/226f3j00yPcknqNdPSbT/Raw-Materials-Finished-Products-in-Stock-Sermaglutide-Liraglutide-Tirzepatide-Gip-GLP-1-Injection-GLP-CAS-910463-68-2-Treatment.webp)
You can specify delivery way .We are okay with DHL /Fedex/TNT/UPS/EMS or by ship or air
Lead time: Peak season 4-8 days ,off season 3-7days after payment
We have rich experience in customer clearance to Asian countries, USA ,EU,Canada ,100 safe delivery door to door .
FAQ
Q1 Can i get some samples
A1 Yes, we can supply the free sample, but the shipping cost be paid by our customers.
Q2 How to start orders or make payments
A2 Proforma invoice will be sent first after confirmation of order, enclosed our bank information.
Payment by T/T, Western Union or Paypal or Escrow(Alibaba).
Q3 How to confirm the Product Quality before placing orders
A3 You can get free samples for some products,you only need to pay the shipping cost or arrange a courier to us and take the samples. You can send us your product specifications and requests,we will manufacture the products according to your requests.
Q4 What's your MOQ
A4 Our MOQ is 1kg. But usually we accept less quantity such as 100g on the condition that sample charge is 100% paid.
Q5 How about delivery leadtime
A5 Delivery lead time: About 1-3days after payment confirmed. (Chinese holiday not included)
Q6 Is there a discount
A6 Different quantity has different discount.
Q7 How do you treat quality complaint
A7 First of all, our quality control will reduce the quality problem to near zero. If there is a real quality problem caused by us, we will send you free goods for replacement or refund your loss.
GUARANTEE QUALITY OF EACH PRODUCT !
As an researcher and manufacturer of p Shengzhikai Biotech is one of the China's high-performance pharmaceutical intermediate products suppliers. It covers 4 popular research fields including pharmaceutical intermediate ,plant extract ,chemical reagent and chemical intermediate .Existing compounds are continuously expanded to meet the latest research needs.
harmaceutical intermediate , Shengzhikai has good purity, stability activity. Our core philosophy is "guarantee the quality of each product" and is committed to providing comprehensive research materials and reliable product performance for medical research. The products have been widely used by customers around the world. Shengzhikai's mission is to make it easier for scientists around the world to access the most effective intermediate and help them make major scientific discoveries faster. These compounds have a wide range of applications in pharmaceutical studies of human diseases and have a wide range of potential uses.
We have rapid development although we just start over one year .Shengzhikai established stable relationships with many customers. It's main customers include the world's major pharmaceutical companies, biotechnology companies, hospitals and major clinical diagnostic laboratories. Universities, research institutes, and government agencies.
![Raw Materials/Finished Products in Stock Sermaglutide Liraglutide Tirzepatide Gip GLP-1 Injection GLP CAS. 910463-68-2 Treatment](https://image.made-in-china.com/226f3j00wLokNqyJiZca/Raw-Materials-Finished-Products-in-Stock-Sermaglutide-Liraglutide-Tirzepatide-Gip-GLP-1-Injection-GLP-CAS-910463-68-2-Treatment.webp)
![Raw Materials/Finished Products in Stock Sermaglutide Liraglutide Tirzepatide Gip GLP-1 Injection GLP CAS. 910463-68-2 Treatment](https://image.made-in-china.com/226f3j00JLkqOKFcpjbE/Raw-Materials-Finished-Products-in-Stock-Sermaglutide-Liraglutide-Tirzepatide-Gip-GLP-1-Injection-GLP-CAS-910463-68-2-Treatment.webp)
![Raw Materials/Finished Products in Stock Sermaglutide Liraglutide Tirzepatide Gip GLP-1 Injection GLP CAS. 910463-68-2 Treatment](https://image.made-in-china.com/226f3j00dLokFwNZesqT/Raw-Materials-Finished-Products-in-Stock-Sermaglutide-Liraglutide-Tirzepatide-Gip-GLP-1-Injection-GLP-CAS-910463-68-2-Treatment.webp)
![Raw Materials/Finished Products in Stock Sermaglutide Liraglutide Tirzepatide Gip GLP-1 Injection GLP CAS. 910463-68-2 Treatment](https://image.made-in-china.com/226f3j00TPkbyUnhZsoG/Raw-Materials-Finished-Products-in-Stock-Sermaglutide-Liraglutide-Tirzepatide-Gip-GLP-1-Injection-GLP-CAS-910463-68-2-Treatment.webp)